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Abstract
Background:  Proper histomorphological interpretation of intestinal acute graft versus host
disease (A-GVHD) associated with allogeneic bone marrow transplantation (BMT) is critical for
clinical managaement. However, studies methodically evaluating different histomorphological
features of A-GVHD are rare.
Methods: Colonic biopsies from 44 allogeneic BMT patients having biopsy-proven cutaneous A-
GVHD were compared with colon biopsies from 48 negative controls.
Results: A-GVHD showed intra-cryptal apoptosis in 91% and pericryptal apoptosis in adjacent
lamina propria in 70% (p < 0.002). Nonspecific apoptosis along the surface epithelium was observed
in all groups with comparable frequency. The number of apoptotic cells in mucosa were
approximately four times (5.3 per 10 HPF) the negative controls (p < 0.002) in A-GVHD group.
48% of cases with A-GVHD showed decreased number of lymphocytes in lamina propria. Some
features, including intraepithelial lymphocytes in surface or crypt epithelium; and neutrophils,
eosinophils, and edema in lamina propria, did not demonstrate significant difference in A-GVHD
and negative controls. Pericryptal apoptosis, dilated crypts, irregular distribution of crypts,
decreased lymphocytes, increased microvessel network, focal fibrosis, presence of muciphages,
reactive changes in surface epithelium with mucin depletion, mucosal ulceration, and/or reduced
mucosal thickness showed higher association with A-GVHD group.
Conclusions: Intracyptal apoptosis is a reliable indicator of A-GVHD. Its diagnostic significance
was improved if intracyptal apoptosis was associated with features which were observed more
frequently in A-GVHD group as mentioned above.
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Background
Acute graft versus host disease (A-GVHD) is a significant
cause of morbidity and mortality following allogeneic
bone marrow transplantation (BMT). It frequently in-
volves skin, intestinal tract, and liver. The incidence of A-
GVHD after allogeneic BMT ranges from 30% to 60% with
skin as the most commonly affected organ often accompa-
nied by intestinal and / or liver involvement [1–4]. Intes-
tinal A-GVHD may manifest as abdominal cramps, ileus,
profuse diarrhea, and sometimes bleeding. However,
these symptoms are not specific and include broad differ-
ential diagnoses such as chemotherapy effect, radiation
therapy effect, infections, and side effects of other drugs
[5–9]. Furthermore, the histomorphological features of
these conditions overlap significantly with A-GVHD. Due
to this, interpretation of colonic biopsies for intestinal A-
GVHD may be a major diagnostic challenge especially for
those not conversant with these findings [10]. Only a few
studies have statistically evaluated the diagnostic signifi-
cance of some histopathological features [6]. A-GVHD is
treated with immunosuppression which may worsen an
underlying infective condition. Thus it is extremely im-
portant to diagnose these conditions correctly for proper
management.
In addition to other histopathological features described
in association with A-GVHD, significance of apoptosis,
crypt abscess, and crypt loss has been emphasized [4,11–
15]. However, the distribution pattern of apoptosis in co-
lonic mucosa in A-GVHD has not been methodically eval-
uated. Similarly the term 'crypt abscesses' has been used
previously in A-GVHD, although it appears to be a misno-
mer as discussed later. This may lead to confusion with
'crypt abscess' of inflammatory bowel disease. 'Crypt ab-
scess' and 'cryptitis' associated with inflammatory bowel
diseases, not been evaluated in intestinal A-GVHD previ-
ously, were specifically studied to confirm the misnomer
status.
We retrospectively analyzed various histomorphological
features in 44 colon biopsies from BMT patients with cu-
taneous A-GVHD and diarrhea. These were compared
with 48 colon biopsies from negative control groups. The
goal of this study was to systematically evaluate the diag-
nostic reliability of various histomorphological features
with reference to intestinal A-GVHD.
Methods
Group Definitions
The colonic biopsies from 92 patients were evaluated ret-
rospectively using archival material and were divided into
three categories (group A- 44, group B- 27, and group C-
21). Group A included BMT cases with biopsy proven cu-
taneous A-GVHD. All cases in group A were allogeneic
BMT and none received peripheral blood stem cell or cord
blood transplantation. They received the same condition-
ing regimen (cyclophosphamide [Cytoxan], cytosine ara-
binoside, and total body irradiation). The type of A-
GVHD prophylaxis used was post-transplatation cy-
closporin A. Group B and C included negative controls.
Group A
Consisted of 44 patients (25 males and 19 females, 19 to
59 years of age, mean 41.6 years) with diarrhea and biop-
sy proven cutaneous A-GVHD. In this group, intestinal A-
GVHD was strongly favored, in the absence of other etiol-
ogies such as CMV colitis and NSAIDs [2,4,7,9,12,16,17].
CMV colitis cases were excluded morphologically based
on the presence of CMV cytopathic effect or CMV immu-
nohistochemistry. The cases with suspicious features such
as ill defined cytopathic changes and ischemic features
were also automatically excluded without performing
CMV immunohistochemistry to avoid possibility of inclu-
sion of cases with CMV. These 44 colon biopsies were per-
formed 21 to 100 day post-BMT (median 35 days) prior
to the commencement of treatment for A-GVHD and
within 15 days of A-GVHD positive skin biopsy for inves-
tigating their diarrhea.
The underlying indications for BMT in these 44 cases in
group A are shown in Table 1. The distribution of cases
with reference to the grading of cutaneous A-GVHD in-
cluded, 20 cases with grade I, 13 with grade II, 5 with
grade III, and 6 with grade IV. Published clinical and his-
tological criteria were used to define cutaneous and intes-
tinal A-GVHD [12–14,18,19]. Grading of A-GVHD was
not attempted in colon biopsies.
Group B
(negative control I): Included 27 patients (13 males and
14 females, 20 to 77 years of age, mean 51.5 years) with-
out immunodeficiency, BMT, or any other transplanta-
tion. They had non-specific GI symptoms like diarrhoea
and abdominal cramps without inflammatory bowel dis-
ease. The histopathology was negative for any diagnostic
pathology with nonspecific changes or normal colonic
mucosa.
Group C
(negative control II): Included 21 kidney transplant pa-
tients (14 males and 7 females, 46 to 75 years of age,
mean 60.3 years) with non-specific GI symptoms like di-
arrhea and guaiac positive stool. The sections of colon bi-
opsies were histopathologically negative for diagnostic
pathology. These patients in group C were under main-
tainance immunosupressive therapy with cyclosporine or
tacrolimus, prednisone, and mycophenalate mofetil. This
group was included to study if any of the histomorpholog-
ical features evaluted in this study have significantBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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relationship with transplantation in general including ef-
fect of immunosupressive therapy.
Subclinical A-GVHD in the absence of cutaneous A-
GVHD or gastrointestinal symptoms is known [4,10]. Be-
cause of this reason a fourth hypothetical control group of
biopsies from BMT patient without A-GVHD though de-
sired was considered impractical, as various criteria under
scrutiny in this study will be deciding if those biopsies
would have to be considered negative for A-GVHD. Other
negative control group desired would be colonic biopsies
from the cases undergoing all the therapy components of
BMT including cytoreductive therapy but without BMT.
However, such a group would also be impractical during
any clinical study due to obvious ethical limitations. Au-
tologous BMT case without cyclosporine induced GVHD
or viral infection would have been ideal control [28,29].
However, due to limited number of cases in this group we
could not include such a group.
Histomorphological features secondary to the effects of
non-steroidal anti-inflammatory drugs (NSAIDs) [4,7]
and intestinal infections, especially cytomegalovirus
(CMV) [2,9,12,16,17] are known to overlap with A-
GVHD. Due to this, based on clinical details, the cases
with such associations were excluded from this study.
General information
Polyethylene glycol solution (GoLytely®, Braintree Labo-
ratories, Braintree, MA) was used for endoscopic prepara-
tion in all the groups. Due to known subtle differences
between left and right side of the colon, the proportion of
different sites in each group was matched for statistical
correction. All colon biopsies were fixed in Bouin's fixa-
tive and processed routinely. Multiple levels of paraffin-
embedded tissue sections stained with H&E were exam-
ined in blinded fashion without knowing the category.
Histopathological Analysis
Various histological features important for the differential
diagnosis of A-GVHD were selected after review of litera-
ture [12–14]. All H&E stained sections were evaluated
qualitatively or semi-quantitatively for histomorphologi-
cal features shown in table 2.
The mucosal thicknesses (Table 2, A) from the surface ep-
ithelium to the internal limit of muscularis mucosa in
three places were measured in the area of least thickness
and mean was calculated. Thickness > 500 microns was
considered within normal limits [20]. Cryptitis and crypt
abscess were defined respectively as infiltration of crypt
epithelium with neutrophils and presence of neutrophils
in crypt lumen (Table 2, F). Five or fewer intraepithelial
lymphocytes per 100 epithelial cells in surface and crypt
lining were considered to be within normal limits (Table
2, G and H) [21]. We classified 1–5 extravascular
neutrophils per 20 inflammatory cells in the lamina pro-
pria (LP) as mild increase and more than five as marked
increase (Table 2, L). Macrophages with mucin as faintly
basophilic foamy cytoplasm in H&E stained sections were
identified as muciphages. Five or more muciphages in LP
per 10 crypts were considered significant (Table 2, P).
Presence of five or more endothelial lined blood spaces
larger than 50 microns for every 10 crypts was regarded as
increased microvessel network (Table 2, Q). Apoptosis
(defined as single cell death) was indentified in H&E
stained sections as apoptotic cells with scattered karyor-
rhectic basophilic globular intracytoplasmic debris of ap-
Table 1: Group definitions and demographics of the cases studied.
Group A Group B Group C
Positive group with A-GVHD by skin biopsy*.
Cases of BMT. Underlying indications for BMT are 
shown as the foot notes of this table**.
With diarrhea and without identifiable infectious etiology 
and history of drugs like NSAIDs, steroids.
Negative control group I.
Without any transplantation and 
immunosupresion.
With GI symptoms like diarrhea, guaiac 
positive stool.
Negative control group II.
With kidney transplantation***.
With GI symptoms like diarrhea, guaiac 
positive stool.
Age
Mean 41.6 years 51.5 years 60.3 years
SD 9.2 12.5 8
Range 19 to 59 years 20 to 77 years 46 to 75 years
Sex
Males 25 13 14
Females 19 14 7
Total 44* 27 21
*The splitting of total cases according to the grading of cutaneous A-GVHD: Grade I- 20, Grade II- 13, Grade III- 5, Grade IV- 6. **The diagnoses for 
which BMT was done includes: Hodgkin's Lymphoma (3), Non-Hodgkin's Lymphoma (4), T-cell Lymphoblastic Lymphoma (5), IgG Multiple myeloma 
(3), Plasma cell leukemia (1), Chronic Myelogenous Leukemia (17), Chronic myelomonocytic Leukemia (2), Myelodysplastic syndrome (1), and Oth-
ers (8). All cases received the same conditioning regimen (cyclophosphamide [Cytoxan], cytosine arabinoside, and total body irradiation). The type 
of A-GVHD prophylaxis used was post-transplatation cyclosporin A. ***The duration of kidney transplantation ranged from 8 to 64 months (mean 
28 months).BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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optotic bodies (Figure 1). Apoptotic cells were counted in
10 high power field (HPF) at 40 × magnification with a
field diameter of 0.35 mm. Mitotic figures were counted
per 10 crypts (Table 3).
Statistical Analysis
Each group was evaluated for the frequency of various his-
tomorphological features shown in table 2. The findings
in group A were compared with groups B and C using
Fisher's exact test (Table 2). Number of apoptotic cells and
mitotic figures in group A were compared with those in
groups B and C using Wilcoxan Rank Sum Test (Table 3).
In order to compensate for the multiple testing and thus
to avoid imparting spurious significance, we used a strin-
gent significance level of 0.002 for each test. This was
based on the Bonferroni correction factor for multiple
testing to achieve an overall significance level of 5% [22].
Histomorphological features with statistically significant
differences were separated for further analysis (Table 4).
Results
The comparative frequency of various histomorphological
features observed in all the three groups is shown in table
2. Apoptosis in crypt lining was associated with higher fre-
quency in A-GVHD with statisticaaly significant difference
(Table 3 and 4). Other features observed more often in A-
GVHD with statistically significant differences as com-
pared to the negative control groups included (Table 2
and 4, Figure 2): pericryptal apoptosis adjacent to the
crypts in LP, crypt abnormalities (including crypt size var-
iation, crypt dilatation and irregular crypt distribution),
Figure 1
Colonic biopsy with GVHD. A. Colonic mucosa with apoptotic bodies in crypts. Inset- Crypts show many apoptotic bodies 
(for higher magnification of the crypt with arrow see figure 1B). B. Magnified crypt shown in the inset of figure 1A: The crypt 
shows "popcorn" lesions (arrows) with occasional muciphages (arrowhead) in LP.
A A B BBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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Table 2: Comparison of histological features in group A with A-GVHD and negative controls in group B & C.
Frequency of the histological features in %
Histological features evaluated Negative control
A-GVHD Grp A (n= 44) Grp B (n= 27) Grp C (n= 21)
A Reduced mucosal thickness 47.73% 0.00%* 0.00%*
B Mucosal ulceration 27.27% 0.00%* 0.00%*
C Reactive changes in superficial epithelium 41.86% 0.00%* 0.00%*
D1 Size variation 97.73% 29.63%* 14.28%*
D2 Crypt abnormalities Irregular distribution 63.64% 3.70%* 0.00%*
D3 Crypt dropout 30.23% 0.00%* 0.00%*
E Crypt dilatation 72.73% 3.70%* 0.00%*
F Cryptitis and crypt abscess 2.27% 0.00% 4.76%
G Increased intraepithelial lymphocytes in superficial epithe-
lium
6.98% 0.00% 0.00%
H Increased intraepithelial lymphocytes in crypts 6.98% 0.00% 0.00%
I Intraepithelial neutrophils in superficial epithelium 9.30% 0.00% 0.00%
J Intraepithelial neutrophils in crypts 6.82% 0.00% 0.00%
K1 Intraepithelial in SE 76.74% 77.78% 57.4%
K2 Intracryptal ("popcorn") 90.91% 11.11%* 14.28%*
K3 Distribution of apoptosis Lamina propria, near SE 79.55% 70.37% 85.7%
K4 Pericryptal 70.45% 22.22%* 4.76%*
L0 None 59.09% 74.07% 57.14%
L1 Neutrophils in lamina 
propria
Marked increase 4.55% 18.52% 00.00%
L2 Mild increase 36.36% 11.11% 42.85%
M0 Eosinophils in lamina 
propria
Few to none 100% 96.30% 100.00%
M1 many 0.00% 3.70% 0.00%
N Focal periglandular infiltrate 6.98% 0.00% 0.00%
O1 Edema in lamina propria Focal 86.36% 88.88% 28.57%
O2 Diffuse 4.55% 0.00% 0.00%BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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reactive changes in LP (including reduced mucosal thick-
ness, muciphages in LP, increased microvessel network,
and focal fibrosis), and reactive changes in the surface ep-
ithelium with mucin depletion.
Apoptosis in crypt lining was observed in 91% of group A
cases with A-GVHD and demonstrated statistically signif-
icant difference as compared to negative control group B
and C (p < 0.002, Fisher's exact test) (Table 2 K2, Figure 1).
In group A, 70 % of cases showed apoptotic cells in LP
around the crypts as compared to 22 % in group B and 5
% in group C (p < 0.002) (Table 2 K4). Apoptosis in the
surface epithelium did not show any significant difference
between the three groups (Table 2 K1). Apoptotic bodies
in LP adjacent to the surface epithelium were also non-
specific and did not show significant difference between
the three groups (Table 2 K3). An average 5.3 apoptotic
cells per 10 HPF were observed in group A, in contrast to
only 1.25 in group B and 1.42 in group C (p < 0.002, Wil-
coxan Rank Sum Test) (Table 3).
Intraepithelial lymphocytes and neutrophils in the surface
epithelium and the crypt epithelium did not show statis-
tically significant difference in A-GVHD group and nega-
tive controls (Table 2, G,H,I,J). Neutrophils, eosinophils,
and edema in LP were nonspecific and were observed with
comparable frequencies in all the three categories (Table
2, L,M,O). The number of mitotic figures in crypt lining
did not show statistically significant difference between
the three groups (Table 3).
Discussion
Some of the histological features of A-GVHD in colonic
biopsies have been studied and reported previously
[6,11,14,23]. But they have not been evaluated together as
collective features with methodical statistical analysis.
Crypt cell apoptosis has been described as a significant
finding in intestinal A-GVHD. Usually this is focal in na-
ture and results in membrane bound debris of apoptotic
bodies in the crypts. This phenomenon has been labeled
variously as "exploding crypt cells" [13,24], "karyolytic
body [1,12,14], "apoptotic body" [1,12], "granular necro-
sis", [2] and "popcorn lesions" [2,13] (Figure 1). Though
P Muciphages in lamina propria 43.18% 0.00%* 4.76%*
Q Increased microvessel 
network in lamina 
propria
61.36% 0.00%* 0.00%*
R Clusters of enterochromaffin cells 0.00% 0.00% 0.00%
S1 Fibrosis in lamina propria Focal 47.73% 0.00%* 0.00%*
S2 Diffuse 2.27% 0.00% 0.00%
n, total number of cases in a group; SE, surface epithelium. * Statistically significant difference with p values less than 0.002 with Fisher's exact test 
when A was compared with B and C individually.
Table 3: The comparison of frequencies of apoptotic cells and mitotic figures in colon biopsies.
Negative controls
Group A Group B Group C
Number of apoptotic cells (per 10 HPF, X40, 
FD- 0.35 mm).
Mean 5.29* 1.25* 1.42*
Range 1 to 50 0 to 3 1 to 3
SD 8.49 0.90 0.60
Number of mitotic figures in crypt lining (per 
10 crypts).
Mean 2.65 1.88 2.28
Range 1 to 10 1 to 5 1 to 7
SD 1.98 1.01 1.80
SD, standard deviation; HPF, high power field, FD, field diameter. *Statistically significant differences between Group A / B and Group A / C respec-
tively. The p values calculated by Wilcoxan Rank Sum Test were less than 0.002.
Table 2: Comparison of histological features in group A with A-GVHD and negative controls in group B & C. (Continued)BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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this lesion is not specific for A-GVHD, it is a cardinal fea-
ture as demonstrated by experimental production of intes-
tinal A-GVHD in the Rhesus monkey [14,25]. It is a
valuable diagnostic feature in the absence of infections es-
pecially CMV [2,4,7,9,12,16,17]. Other critical differential
diagnoses include effects of radiation-chemotherapy
[12,13] and effects of other drugs such as NSAIDs [7].
A higher number of apoptotic bodies were observed in A-
GVHD than in negative controls (Table 3). The
distribution pattern of apoptosis in colon biopsies with A-
GVHD has not been evaluated previously with statistical
analysis. In this study, a statistically significant difference
was noted when the distribution of apoptotic bodies in
crypts and around the crypts was compared with those in
surface epithelium and adjacent to the surface epithelium.
The frequency of apoptotic bodies in surface epithelium
and adjacent LP in all the three groups were comparable
and did not show statistically significant difference (Table
2, K1 and K3). The presence of apoptosis in surface epithe-
lium or in adjacent LP is nonspecific. In the absence of ap-
optosis in the crypts, presence of apoptosis along the
surface epithelium does not have any diagnostic signifi-
cance for A-GVHD. The cause of apoptosis along the sur-
face epithelium is physiological turnover with loss from
the surface epithelium and the replacement by prolifera-
tion of cells in the crypts. Variety of non-specific factors
may accelerate this with increased number of apoptotic
cells along the surface epithelium.
As compared to the negative controls (group B- 11% and
group C- 14%), crypt apoptosis was frequent in A-GVHD-
91% with statistically significant difference (Table 2 K2).
With proper clinical history, the diagnosis of A-GVHD can
be suggested if apoptosis is observed in and around the
crypts. Association of cryptal apoptosis with other features
(Table 4) should increase the diagnostic accuracy. These
associations included reactive changes in the surface epi-
thelium, increased muciphages, reduced mucosal thick-
ness, focal fibrosis in LP, irregular distribution of crypts,
crypt dilatation, and crypt size variation (Table 4). How-
ever, some of these features may be secondary to
cytoreductive therapy and other components of BMT. In
general, the effects of cytoreductive therapy are not ob-
served after 20 days [12]. Under proper clinical situation,
Figure 2
A. Colonic biopsy with GVHD- Focal crypt abnormalities (crypt size variation and irregular crypt distribution) with decreased 
mucosal thickness (x). Inset: Ectatic vessels (y) and slightly dilated crypt (z) with mild decrease in number of lymphocytes in LP. 
B. Colonic biopsy with GVHD (higher magnification of area adjacent to 'x' in figure 2A) – Crypt abnormalities with focal ulcer-
ation (A), focal reactive surface epithelium (b), focal fibrosis (C), and many apoptotic cells in crypts (d).
X X
Z Z
Y Y Y Y
A A
b b
c c
d d
d d
A A B BBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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their association with apoptosis in crypts and pericryptal
apoptosis in LP is consistent with A-GVHD in BMT. Fur-
ther evaluation of these features in relation to individual
components of BMT protocols may be conducted as ani-
mal experiments with proper controls. As mentioned un-
der materials and methods, such evaluation would be
impractical as clinical study due to obvious ethical limita-
tions in organizing proper controls.
Patients with cutaneous and hepatic A-GVHD frequently
have apoptosis in their colon biopsies, without any intes-
tinal symptoms [4]. This may represent sub-clinical intes-
tinal A-GVHD if the apoptosis is observed in relation to
the crypts [10]. If other findings (Table 4) are present in
the absence of crypt apoptosis, it may represent evidence
of past A-GVHD or due to other etiologic factors such as
chronic infections and inflammatory bowel disease.
As noted in this study, classical cryptitis with infiltration
of crypt-lining by neutrophils and crypt abscesses with
neutrophils within crypt lumens observed in inflammato-
ry bowel disease were not features of intestinal A-GVHD
(Table 2, F). 'Cryptitis' has been described in association
with A-GVHD, but these studies do not define the term
[6,12,13]. Although reference had been made to crypt ab-
scesses in these reports, it is evident that the researchers
were looking at the apoptotic debris in gland lumina and
suggested 'crypt abscess-like' changes [14]. In our study,
only one case (2.7%) from group A with A-GVHD showed
occasional crypt abscess (Table 2) and this may represent
a coincidental inflammatory bowel disease – like damage
[26]. Mild cryptitis with a few crypt abscesses was also ob-
served in one patient (4.76%) in group C with kidney
transplantation (Table 2). Thus, classical cryptitis and
crypt abscesses with infiltration of crypt lining and crypt
lumen with neutrophils observed in inflammatory bowel
disease is not a feature of A-GVHD.
A change, that was called focal periglandular infiltrate by
Bombi et al [6], was observed by us in three (6.9%) cases
of A-GVHD involving only one or two crypts (Table 2, N).
Sale and colleagues described a comparable feature with
"focal increase in density of lymphocytes, plasma cells,
and occasional eosinophils in the LP" [13]. This finding
was suggested as a marker for apoptosis favoring the clin-
ical diagnosis of A-GVHD [6]. They have suggested that
the presence of focal periglandular infiltrate warrants a
careful search for cryptal apoptosis. We did not observe
this finding in negative control groups B and C.
The clusters of enterochromaffin cells in A-GVHD have
been reported previously [25,27]. They have been de-
scribed in association with apoptosis, suggesting their
presence as the result of selective sparing of enterochro-
maffin elements during the process of A-GVHD. We did
not observe them in H&E stained sections (Table 2, R).
Conclusions
Apoptosis in crypt lining and pericryptal apoptosis adja-
cent to crypts in LP, especially when associated with the
features such as crypt abnormalities and reactive changes
in mucosa (LP and surface epithelium) favor the diagnosis
of A-GVHD. Cryptitis and crypt abscesses are not feature
of A-GVHD and should be differentiated from "popcorn
Table 4: Summary of diagnostically significant morphological features associated with intestinal A-GVHD¶.
S. No Findings A-GVHD cases Group A 
n= 44
Negative controles 
(B+C)* n= 48
Sp Sn PPV NPV
TP FN TN FP
1. Apoptosis (K2) Apoptosis in crypt lining 40 4 42 6 87 91 93 91
(K4) Pericryptal apoptosis in LP, adjacent 
to the crypts
31 13 41 7 85 70 84 93
2. Crypt 
abnormalities
(D1) Crypt size variation 43 1 37 11 77 98 100 97
(E) Crypt dilatation 32 12 47 1 98 73 97 80
(D2) Irregular distribution of crypts 28 16 47 1 98 64 97 75
3. Reactive 
changes a. In 
lamina propria
(R) Increased LP microvascular network 27 17 48 0 100 61 100 74
(T1)Focal fibrosis in LP 21 23 46 2 96 48 100 67
(A) Reduced mucosal thickness 21 23 48 0 100 48 100 68
(Q) Muciphages in LP 18 26 42 6 87 41 100 62
b. In surface 
epithelium
(C) Reactive changes in SE 18 26 48 0 100 41 100 65
¶Morphological features demonstrating statistically significant association with A-GVHD (selected from Table 2). *Addition of Group B (27) and 
Group C (21). Due to the lack of ideal but practical negative control (as discussed in the text), sensitivities and specificities calculated in this study 
are based on the practical negative controls in group B and C. TP, true positive; FN, false negative; TN, true negative; FP, false positive, LP, lamina 
propria, SE, surface epithelium. Sp, Specificity; Sn, Sensitivity; PPV, Positive predictive value; NPV, Negative predictive value.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/5
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lesions", which show apoptotic cells instead of neu-
trophils along the crypt lining and in the crypt lumen.
List of abbreviations
A-GVHD, Acute graft-versus-host disease; BMT, bone mar-
row transplantation; LP, lamina propria; H&E, hematoxy-
lin and eosin.
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